Canada's Immunotherapy Network
| fr
Home | Contact Us |
  • SUMMIT4CI
    • The Learning Institute
    • Summit4CI Speaker Series
  • NEWS & EVENTS
    • News
    • Newsletters
      • BioCanRx Newsletters
      • CSA Dispatch
    • Media Releases
    • Publications
    • Events
  • PATIENTS
    • About Biotherapeutics
    • Glossary
    • Resources
    • Patient Stories
    • Public Forums
    • BioCanRx-funded Clinical Trials
  • PARTNERSHIPS
    • Working with us
      • Researchers
      • Industry
      • Not-for-profit, charities and patient groups
      • Government
    • Our Partners & Collaborators
  • TRAINING
    • HQP Training Program
    • Learning Opportunities
      • Upcoming Opportunities
      • Online Resources
      • Externally Offered Resources
    • Travel Awards & Lab Exchanges
    • Summer Student Internships
    • Where Are They Now
    • Get Involved!
  • RESEARCH
    • Research Program
      • Areas of Research
      • Research Funding
        • Program descriptions
        • Application process and instructions
    • Project Portfolio
      • Clinical Trials
      • Enabling Projects
      • Catalyst Projects
      • Clinical, Social and Economic Impact Projects
    • Core and Biomanufacturing Facilities
    • Made-in-Canada CAR T Therapy Timeline
    • Researcher Profiles
  • ABOUT
    • About BioCanRx
    • Governance
      • Board of Directors
      • Research Management Committee
      • HQP Development Committee
      • Point-of-Care Cell Manufacturing Committee
      • Equity, Diversity, & Inclusion Committee
      • Cancer Stakeholder Alliance
        • Working Group
      • Network Members
    • Equity, Diversity & Inclusion
      • BioCanRx EDI Priorities & Action Plan
      • BioCanRx Code of Conduct
    • Who we are
      • Our Team
 

Christopher Paige

thumb image

Senior Scientist, Princess Margaret Cancer Centre

 

Full Biography

 

Cancers of Interest

Leukemia

 

Research and clinical approaches

Preclinical development of cancer vaccines

 

Projects at BioCanRx

PHASE I STUDY OF THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) USING AUTOLOGOUS AML CELLS ENGINEERED TO EXPRESS IL-12

Blood cancer Immunotherapy

  • ABOUT
    • About BioCanRx
    • Governance
    • Board of Directors
    • Research Management Committee
    • HQP Development Committee
    • Point-of-Care Cell Manufacturing Committee
    • Equity, Diversity, & Inclusion Committee
    • Cancer Stakeholder Alliance
    • Working Group
    • Network Members
    • Equity, Diversity & Inclusion
    • BioCanRx EDI Priorities & Action Plan
    • BioCanRx Code of Conduct
    • Who we are
    • Our Team
  • RESEARCH
    • Research Program
    • Areas of Research
    • Application process
      and instructions
    • Clinical Trials
    • Enabling Projects
    • Catalyst Projects
    • CSEI Projects
    • Core and Biomanufacturing Facilities
    • Made-in-Canada CAR T Therapy Timeline
    • Researcher Profiles
  • TRAINING
    • HQP Training Program
    • Learning Opportunities
    • Travel Awards & Lab Exchanges
    • Summer Student Internships
    • Where Are They Now
    • Get Involved!
  • PARTNERSHIPS
    • Working with us
    • Researchers
    • Industry
    • Government
    • Not-for-profit,
      charities and patient
      groups
    • Our Partners & Collaborators
  • PATIENTS
    • About Biotherapeutics
    • Glossary
    • Resources
    • Patient Stories
    • Public Forums
    • BioCanRx-funded Clinical Trials
  • NEWS & EVENTS
    • News
    • BioCanRx Newsletters
    • CSA Dispatch
    • Media Releases
    • Publications
    • Events
Diversio Link

Box 611, 501 Smyth Road
Ottawa, ON K1H 8L6
info@biocanrx.com

Copyright 2022, All rights reserved
  • ABOUT
    • About BioCanRx
    • Governance
      • Board of Directors
      • Research Management Committee
      • HQP Development Committee
      • Point-of-Care Cell Manufacturing Committee
      • Equity, Diversity, & Inclusion Committee
      • Cancer Stakeholder Alliance
        • Working Group
      • Network Members
    • Equity, Diversity & Inclusion
      • BioCanRx EDI Priorities & Action Plan
      • BioCanRx Code of Conduct
    • Who we are
      • Our Team
  • RESEARCH
    • Research Program
      • Areas of Research
      • Research Funding
        • Program descriptions
        • Application process and instructions
    • Project Portfolio
      • Clinical Trials
      • Enabling Projects
      • Catalyst Projects
      • Clinical, Social and Economic Impact Projects
    • Core and Biomanufacturing Facilities
    • Made-in-Canada CAR T Therapy Timeline
    • Researcher Profiles
  • TRAINING
    • HQP Training Program
    • Learning Opportunities
      • Upcoming Opportunities
      • Online Resources
      • Externally Offered Resources
    • Travel Awards & Lab Exchanges
    • Summer Student Internships
    • Where Are They Now
    • Get Involved!
  • PARTNERSHIPS
    • Working with us
      • Researchers
      • Industry
      • Not-for-profit, charities and patient groups
      • Government
    • Our Partners & Collaborators
  • PATIENTS
    • About Biotherapeutics
    • Glossary
    • Resources
    • Patient Stories
    • Public Forums
  • NEWS & EVENTS
    • News
    • BioCanRx Newsletters
    • Media Releases
    • Publications
    • Events
  • SUMMIT4CI
    • The Learning Institute
    • Summit4CI Speaker Series